Role of extracellular vesicles in the high-fat diet-induced risk of Alzheimer disease
细胞外囊泡在高脂肪饮食诱发的阿尔茨海默病风险中的作用
基本信息
- 批准号:9385535
- 负责人:
- 金额:$ 19.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-08-01 至 2019-07-31
- 项目状态:已结题
- 来源:
- 关键词:ABCC1 geneABCG2 geneAdultAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease riskAmyloid beta-ProteinAnimal ModelAnimalsBehavioralBindingBloodBlood - brain barrier anatomyBlood VesselsBody WeightBrainC57BL/6 MouseCell CommunicationCell physiologyCellsCellular Metabolic ProcessCerebrumCharacteristicsChronicCognitive deficitsConsumptionDementiaDepositionDevelopmentDiabetes MellitusDietElderlyEndothelial CellsEnergy MetabolismEpidemicFunctional disorderGlucoseGlucose TransporterGoalsHigh Fat DietHumanHypoxiaImmune responseImpaired cognitionInflammationInflammatoryInflammatory ResponseInsulin ResistanceIntravenousLate Onset Alzheimer DiseaseLeadLesionLinkLipopolysaccharidesMeasuresMetabolic syndromeMicroRNAsMicrogliaModelingMolecularMusNerve DegenerationNeurofibrillary TanglesNeuronsNon-Insulin-Dependent Diabetes MellitusObesityP-GlycoproteinPathogenesisPathologicPathologic ProcessesPathologyPathway AnalysisPatientsPeripheralPermeabilityPhysiological ProcessesPreventivePreventive measureProductionProteinsRNAReportingResearchResearch Project GrantsRiskRisk FactorsRodentRoleSLC2A1 geneSenile PlaquesSignal PathwayTestingTherapeuticTight Junctionsamyloid pathologybrain parenchymacell typecirculating microRNAcognitive functioncytokinediabeticdiabetic ratexosomeextracellular vesiclesglucose metabolismglucose uptakehyperphosphorylated tauhypoperfusionimmunoregulationimpaired glucose toleranceimprovedinsulin sensitivitymembermicrovesiclesmouse modelnervous system disorderneurofibrillary tangle formationneuroinflammationoccludinpreventprotein profilingtau Proteinstrenduptake
项目摘要
Project summary/Abstract
Amyloid plaques composed of deposits of abnormally aggregated amyloid β-protein and neurofibrillary tangles
(NFTs) consisting of abnormal aggregates of hyperphosphorylated tau protein in the brain are two main
pathological changes in patients with Alzheimer's disease (AD). Amyloid plaques and NFTs are accompanied
with chronic inflammation characterized by activated microglia and increased cytokines. The causes for the
vast majority of AD cases are unknown and satisfactory therapeutic and preventive measures for AD are
unavailable. Therefore, an urgent need exists to identify the molecular mechanisms that increase the risk for
the vast majority of AD cases and for development of preventive and therapeutic measures. Over 30% of
adults are currently classified as obese in the US and obesity is considered to be responsible for up to 70-90%
of type 2 diabetes mellitus (T2DM) cases. Consumption of high fat diets (HFD) is strongly associated with
obesity and T2DM. Obesity and T2DM are linked to decreases in cognitive functions in older adults and strong
risk factors of AD. Furthermore, AD patients show decreases in glucose uptake and insulin sensitivity in the
brain and have increased risk for developing T2DM. Additionally, obesity and T2DM are main vascular risk
factors and produce a number of macro- and micro-vascular complications including blood-brain barrier (BBB)
dysfunction and inflammation. According to the vascular hypothesis of AD, vascular risk factors including
diabetes, obesity and systemic inflammation induce hypoperfusion, hypoxia and BBB dysfunction, which cause
reduced Aβ clearance across the BBB, accumulation of brain Aβ, and NFT formation, leading to
neurodegeneration and, ultimately, AD dementia. We hypothesize that blood extracellular vesicles (EVs)
associated with obesity and T2DM have the characteristics of RNA and/or protein profiles that induce the BBB
dysfunction, brain glucose hypometabolism and neuroinflammation in the brain, leading to an increased risk
and accelerated progression of AD. RNAs and proteins abundantly found in EVs have important roles in cell-
to-cell communication and are involved in immune regulation, inflammatory responses, cell metabolism,
metabolic syndrome and neurological disorders. In order to test the hypothesis, we will isolate blood EVs from
HFD- and normal chow diet (NCD)-fed mice, intravenously infuse the EVs into AD model mice and determine
body weight, glucose metabolism, BBB changes, AD-like and inflammatory pathology and behavioral functions
(Aim 1). We will determine protein and RNA profiles of blood EVs from AD model, HFD- and NCD-fed mice
and perform their signaling pathway analysis (Aim 2). The immediate goal of this study is to determine the role
of blood EVs produced by chronic consumption of HFD in the AD pathogenesis. If proven true, this project will
open new research avenues to identify specific molecules (microRNAs and/or proteins) in EVs, which are
responsible for the increased risk of AD in obese and T2DM patients and to ultimately prevent and treat AD.
项目概要/摘要
淀粉样斑块由异常聚集的淀粉样 β 蛋白和神经原纤维缠结组成
(NFT)由大脑中过度磷酸化 tau 蛋白的异常聚集体组成,主要有两种
阿尔茨海默病(AD)患者的病理变化伴随着淀粉样斑块和NFT。
以小胶质细胞激活和细胞因子增加为特征的慢性炎症。
绝大多数AD病例是未知的,并且令人满意的AD治疗和预防措施
因此,迫切需要确定增加风险的分子机制。
绝大多数 AD 病例,并制定了超过 30% 的预防和治疗措施。
目前美国成年人被归类为肥胖,肥胖被认为是造成高达 70-90% 的原因
2 型糖尿病 (T2DM) 病例的摄入与高脂饮食 (HFD) 相关。
肥胖和 T2DM 肥胖和 T2DM 与老年人和强者认知功能下降有关。
AD 的危险因素此外,AD 患者的葡萄糖摄取和胰岛素敏感性降低。
此外,肥胖和 T2DM 是主要的血管风险。
因素并产生许多大血管和微血管并发症,包括血脑屏障(BBB)
根据AD的血管假说,血管危险因素包括
糖尿病、肥胖和全身炎症会导致低灌注、缺氧和血脑屏障功能障碍,从而导致
跨 BBB 的 Aβ 清除减少、大脑 Aβ 积累和 NFT 形成减少,导致
我们与血液细胞外囊泡 (EV) 作斗争。
与肥胖和 T2DM 相关的 RNA 和/或蛋白质谱特征可诱导 BBB
功能障碍、脑葡萄糖代谢低下和大脑神经炎症,导致风险增加
EV 中大量存在的 RNA 和蛋白质的加速进展在细胞中发挥着重要作用。
细胞通讯并参与免疫调节、炎症反应、细胞代谢、
为了验证这一假设,我们将从代谢综合征和神经系统疾病中分离出血液 EV。
HFD 和正常饮食 (NCD) 喂养的小鼠,将 EV 静脉注射到 AD 模型小鼠中并确定
体重、葡萄糖代谢、BBB 变化、AD 样和炎症病理学以及行为功能
(目标 1)我们将确定 AD 模型、HFD 和 NCD 喂养小鼠的血液 EV 的蛋白质和 RNA 谱。
并进行信号通路分析(目标 2)。本研究的直接目标是确定其作用。
长期食用 HFD 所产生的血液 EV 在 AD 发病机制中的作用 如果证实属实,该项目将得到证实。
开辟新的研究途径来识别 EV 中的特定分子(microRNA 和/或蛋白质),这些分子是
负责增加肥胖和 T2DM 患者患 AD 的风险,并最终预防和治疗 AD。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ken-ichiro Fukuchi其他文献
Ken-ichiro Fukuchi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ken-ichiro Fukuchi', 18)}}的其他基金
Role of MyD88 signaling in systemic inflammation and Alzheimer disease
MyD88 信号在全身炎症和阿尔茨海默病中的作用
- 批准号:
10456872 - 财政年份:2021
- 资助金额:
$ 19.99万 - 项目类别:
Role of MyD88 signaling in systemic inflammation and Alzheimer disease
MyD88 信号在全身炎症和阿尔茨海默病中的作用
- 批准号:
10314883 - 财政年份:2021
- 资助金额:
$ 19.99万 - 项目类别:
Role of MyD88 signaling in systemic inflammation and Alzheimer disease
MyD88 信号在全身炎症和阿尔茨海默病中的作用
- 批准号:
10611489 - 财政年份:2021
- 资助金额:
$ 19.99万 - 项目类别:
Altering immune tolerance in Alzheimer disease
改变阿尔茨海默病的免疫耐受性
- 批准号:
9979733 - 财政年份:2019
- 资助金额:
$ 19.99万 - 项目类别:
Role of diet-induced miR-34a in Alzheimer disease and dementia
饮食诱导的 miR-34a 在阿尔茨海默病和痴呆中的作用
- 批准号:
9225329 - 财政年份:2017
- 资助金额:
$ 19.99万 - 项目类别:
Role of the MyD88-independent pathway in Alzheimers disease
MyD88 独立通路在阿尔茨海默病中的作用
- 批准号:
8511261 - 财政年份:2013
- 资助金额:
$ 19.99万 - 项目类别:
Role of the MyD88-independent pathway in Alzheimers disease
MyD88 独立通路在阿尔茨海默病中的作用
- 批准号:
8676620 - 财政年份:2013
- 资助金额:
$ 19.99万 - 项目类别:
Catalytic and non-catalytic Ig gene delivery for Alzheimer's disease
阿尔茨海默病的催化和非催化 Ig 基因递送
- 批准号:
7963696 - 财政年份:2010
- 资助金额:
$ 19.99万 - 项目类别:
Catalytic and non-catalytic Ig gene delivery for Alzheimer's disease
阿尔茨海默病的催化和非催化 Ig 基因递送
- 批准号:
8081811 - 财政年份:2010
- 资助金额:
$ 19.99万 - 项目类别:
Innate immunity in Alzheimer's disease: Role of toll-like receptor signaling
阿尔茨海默氏病的先天免疫:Toll 样受体信号传导的作用
- 批准号:
7904117 - 财政年份:2009
- 资助金额:
$ 19.99万 - 项目类别:
相似国自然基金
ABCG2基因421/34位多态双杂合突变的顺反式类型对BCRP功能影响及其机制研究
- 批准号:81603197
- 批准年份:2016
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
胎盘转运体编码基因ABCB1及ABCG2多态性对胎盘药物转运的影响及机制研究
- 批准号:81560252
- 批准年份:2015
- 资助金额:38.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Identification, Quantification, and Functional Characterization of Transporters in Human Placenta, Developing Gut and Fetal Brain
人胎盘、肠道和胎儿大脑发育中转运蛋白的鉴定、定量和功能表征
- 批准号:
10746192 - 财政年份:2023
- 资助金额:
$ 19.99万 - 项目类别:
Development of 18F PET radiotracers for M2 microglia as diagnostics for multiplesclerosis pathogenesis
开发用于 M2 小胶质细胞的 18F PET 放射性示踪剂作为多发性硬化症发病机制的诊断
- 批准号:
10440539 - 财政年份:2022
- 资助金额:
$ 19.99万 - 项目类别:
Influence of fluoxetine on the disposition kinetics of dolutegravir among people living with HIV with major depression in Nigeria
氟西汀对尼日利亚患有重度抑郁症的 HIV 感染者中多替拉韦处置动力学的影响
- 批准号:
10677687 - 财政年份:2022
- 资助金额:
$ 19.99万 - 项目类别:
Influence of fluoxetine on the disposition kinetics of dolutegravir among people living with HIV with major depression in Nigeria
氟西汀对尼日利亚患有严重抑郁症的 HIV 感染者中多替拉韦处置动力学的影响
- 批准号:
10538663 - 财政年份:2022
- 资助金额:
$ 19.99万 - 项目类别:
MERTK/AXL dual inhibitors provide novel treatment for cancer by targeting tumor cells and activating anti-tumor immunity
MERTK/AXL双重抑制剂通过靶向肿瘤细胞并激活抗肿瘤免疫为癌症提供新的治疗方法
- 批准号:
10373031 - 财政年份:2020
- 资助金额:
$ 19.99万 - 项目类别: